Stocktoria
ADMA BIOLOGICS, INC. ADMA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2013-10-17
ADMA BIOLOGICS, INC. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 18,644,711 | $208.4M |
| CITADEL ADVISORS LLC | 6,247,242 | $56.3M |
| MILLENNIUM MANAGEMENT LLC | 3,434,449 | $30.9M |
| Point72 Asset Management, L.P. | 3,309,657 | $29.8M |
| TWO SIGMA INVESTMENTS, LP | 2,092,133 | $18.9M |
| RENAISSANCE TECHNOLOGIES LLC | 1,262,634 | $11.4M |
| D. E. Shaw & Co., Inc. | 560,827 | $5.1M |
| AQR CAPITAL MANAGEMENT LLC | 514,789 | $4.6M |
Source: SEC EDGAR filings · CIK 0001368514 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.